The Library of Congress >  Researchers >  Search Finding Aids  >  Frances Oldham Kelsey papers, 1890-2016

Frances Oldham Kelsey papers, 1890-2016

Contact UsHelpSearch All Finding Aids
Access restrictions apply.Some or all content stored offsite.
Part I: Research File, 1917-1998 (continued)
BOX I:18 Subcommittee on Health and Scientific Research, Senate Committee on Labor and Human Resources, hearing and exhibits, 1980, undated
BOX I:18 Dornwal, 1961-1964, undated
BOX I:18 Drug efficacy study, National Academy of Sciences-National Research Council, 1969, undated
BOX I:18 Drug Research Board, National Academy of Sciences-National Research Council, 1965
BOX I:18 Dyes, 1936, 1960-1989, undated
BOX I:18 Elavil, 1961-1963, undated
BOX I:18 Equal rights for women in the federal government, 1962-1972
BOX I:18 Estrogenic substances in plants, 1959, undated
BOX I:19 Fluoridation, 1960-1979, 1990, undated
(4 folders)
BOX I:19 Fluorouracil, 1961-1962, undated
BOX I:19 Furaltadone (Altafur), 1961
BOX I:19 Galega, 1965-1967
BOX I:19 Gestest, 1961, undated
BOX I:19 Hi and Dry (cream deodorant), 1961, undated
BOX I:19 Hypertension, 1961-1962, undated
BOX I:19 International Clearinghouse for Birth Defects Monitoring Systems, 1972-1978, undated
BOX I:19 Investigational Drug Branch, U.S. Food and Drug Administration, 1966
BOX I:19 Investigational new drugs (INDs)
BOX I:19 Adverse comments, Division of Toxicological Evaluation, 1966
BOX I:19 Comments on regulatory procedures, 1961-1975, undated
(2 folders)
BOX I:20 Division of Oncology and Radiopharmaceutical Drug Products, U.S. Food and Drug Administration, 1966-1967
BOX I:20 Inventory of early INDs, 1963
BOX I:20 Proposed regulations and revisions, 1938, 1962-1975, undated
BOX I:20 Regulatory language, series form paragraphs, undated
BOX I:20 Treatment, 1981-1990
(2 folders)
BOX I:20 Kevadon See Container I:33 , Kevadon literature
BOX I:20 Krebiozen, 1959-1982, undated
BOX I:20 Lactostat and climacterin, 1961-1962, undated
BOX I:21 Laetrile, 1967-1983, undated
(5 folders)
BOX I:21 Lavema, 1961, undated
BOX I:21 Leake, Chauncey Depew
BOX I:21 Obituary, 1978
BOX I:21 "Preserving Our Science Archives," Science, 1960
BOX I:21 Lentran, 1961-1962, undated
BOX I:21 Ley, Herbert L., testimony regarding drug testing problems and the role of the U.S. Food and Drug Administration, 1969
BOX I:21 Librium, 1961-1962, undated
BOX I:21 Lin, Chíao-chih, and other Chinese physicians on tour in the United States, 1945, 1972
BOX I:21 Listica, 1960-1962, undated
BOX I:21 Lithium, 1966
BOX I:21 LSD (Drug), 1994
BOX I:21 Medical Fluid 360, 1966
BOX I:21 Megazyme, 1962, undated
BOX I:22 Mental Health Law Project (phenothiazines in institutions), 1964-1974
BOX I:22 Meprobamate, 1958-1966
BOX I:22 Merital, 1986-1990
(2 folders)
BOX I:22 Methotrexate, 1961
BOX I:22 Miscellany, 1963-1996, undated
BOX I:22 MK 665 (Drug), 1966
BOX I:22 Monase, 1960-1963, undated
BOX I:22 Myosed, 1961-1962, undated
BOX I:22 National Center for Drugs and Biologics, U.S. Food and Drug Administration, 1972, 1983-1984
BOX I:22 National Library of Medicine, Bethesda, Md., computerization of scientific information, 1961-1964
BOX I:22 New drug applications (NDAs), U.S. Food and Drug Administration
BOX I:22 Logs, 1957-1961
(2 folders)
BOX I:23 Reviews, 1963
BOX I:23 New Drug Branch, U.S. Food and Drug Administration, 1960
BOX I:23 Nicotinamide adenine dinucleotide (NAD), 1966-1968, 1989
BOX I:23 Nitrogen mustards, undated
BOX I:23 Nobrium, 1956-1962, undated
BOX I:23 Norlutin, 1961, undated
BOX I:23 Ocular Drug Toxicities Symposium, Bethesda, Md., 1966-1971
BOX I:23 Orphan drugs, 1977-1992
BOX I:23 Parotin, 1963
BOX I:23 Patient package inserts, 1969-1990, undated
(2 folders)
BOX I:23 Potassium thiazide, 1964-1965, undated
BOX I:23 Practolol, 1980
BOX I:23 Preludin, 1957-1962, undated
BOX I:23 Prescribing authority for pharmacists, 1983
BOX I:23 Prescription drug labeling, 1969-1990, undated
BOX I:23 Procaine with polyvinylpyrrolidone (PVP)
BOX I:23 1964-1980
BOX I:24 1983-1986, undated
(2 folders)
BOX I:24 Prodilidine, 1961-1962, undated
BOX I:24 Progonasyl, 1971-1973
BOX I:24 Propoquin, 1962, undated
BOX I:24 Quackery
BOX I:24 1954-1988
(4 folders)
BOX I:25 1989-1992, undated
(2 folders)
BOX I:25 Radiochromate injection, 1961, undated
BOX I:25 Radio-rose bengal, 1961-1962, undated
BOX I:25 Ramps (Campanula rapunculus), 1969-1977
BOX I:25 Rand cancer vaccine, 1966-1967
BOX I:25 Rectalad, undated
BOX I:25 Reports
BOX I:25 Annual reports, Center for the Study of Drug Development, 1985-1987
BOX I:25 Checks and balances in the practice of medicine and pharmacy: issues in prescribing and dispensing drugs, Medicine In the Public Interest, 1988
BOX I:26 Commissioner's report of investigation of charges, joint hearings, Subcommittee on Health, Labor and Public Welfare Committee; Subcommittee on Administrative Practice and Procedure, Judiciary Committee, U.S. Senate (15-16 August 1974), 1975
BOX I:26 Drug efficacy study, National Academy of Sciences, 1969
BOX I:26 Drug information for the biomedical community: a report of a preliminary study of the needs for a national drug information clearinghouse, Institute for Advancement of Medical Communication, 1963
BOX I:26 An experiment in early post-marketing surveillance of drugs, IMS America, 1978
BOX I:26 Final report of the Tuskegee syphilis study ad hoc advisory panel, Department of Health, Education, and Welfare, 1973
BOX I:26 Findings and recommendations of the review panel on new drug regulation, Commissioner of Food and Drugs, 1978
BOX I:27 Maximizing the benefits of antibiotics, Medicine In the Public Interest, 1986
BOX I:27 Medical dark ages circa 1984 or cancer alternative therapies' cure rates, Ralph R. Hovnanian, 1984
BOX I:27 Miscellany, 1959-1964
BOX I:27 Post-approval pharmaceutical research and development, Medicine In the Public Interest, 1988
BOX I:27 Prescription drug information for patients and direct-to-consumer advertising, Medicine In the Public Interest, 1984
BOX I:27 Report on the conference on clinical pharmacology, National Academy of Sciences, 1971
BOX I:27 Review of studies of the effect induced in animals and man by the administration of the nonnutritive sweetening agent saccharin, Bureau of Science-Bureau of Medicine, 1970
BOX I:27 Therapeutic substitution symposium, Medicine In the Public Interest, 1986
BOX I:27 Revici, Emanuel, controversy regarding clinical investigation of selenium diethyl dithiocarbonate (SDD) as a treatment for cancer, 1989-1996, undated
BOX I:27 Ritalin, 1958-1961, undated
BOX I:27 Rutherford v. United States, deposition of Kelsey regarding cancer treatment, 1977
BOX I:27 Secozole, 1962
BOX I:27 Shoe-fitting fluoroscopes, 1949-1969, undated
BOX I:27 Silicone injection, 1966-1975
BOX I:27 Somnafac, 1961-1963, undated
BOX I:27 Strilexate, 1961-1962, undated
BOX I:28 Subacute myelo-optico-neuropathy (SMON), 1978-1984 (2 folders)
BOX I:28 Subject studies in vulnerable populations
BOX I:28 Fetuses, infants, and children, 1961-1991, undated
(3 folders)
BOX I:28 Geriatrics
BOX I:28 1959-1980
BOX I:29 1981-1993, undated
Next Page »

Contents List